INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2014
Net Assets |
£180m |
Net Assets per share |
327p |
Share price |
271p |
Total value of unquoted investments |
£23m |
Total number of portfolio companies |
92 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
7.6 |
Alexion |
7.3 |
Biogen |
6.9 |
Celgene |
5.9 |
Amgen |
4.0 |
Regeneron |
3.6 |
Mylan |
3.3 |
Aptiv |
3.1 |
Illumina |
3.1 |
Vertex |
3.0 |
|
----------- |
Total |
47.8 |
Portfolio Profitability |
% NAV |
Profitable |
59 |
Turning Profitable 2015 |
10 |
Unprofitable |
31 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
91 |
Europe & UK |
9 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
87 |
Unquoted |
13 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
29 MAY 2014